Rights and permissions
About this article
Cite this article
Infliximab cost effective for ankylosing spondylitis in the UK. Pharmacoecon. Outcomes News 462, 7 (2004). https://doi.org/10.2165/00151234-200404620-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404620-00011